Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Suzhou Basecare Medical Corp. Ltd. Class H ( (HK:2170) ) has issued an announcement.
Suzhou Basecare Medical Corp. Ltd. announced a significant increase in its revenue for the year ending December 31, 2024, driven by strategic global partnerships and successful market penetration of new medical devices. The company’s acquisition of BMX Holdco Pte. Ltd. enabled international sales growth, while collaborations in North America and China, alongside the introduction of new products such as cryopreservation systems and gene sequencers, bolstered its industry presence.
More about Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corp. Ltd. is a company based in China, operating in the medical industry. It focuses on the development and sales of medical devices and products, with a significant emphasis on areas such as andrology testing, embryo culture, cryopreservation, and gene sequencing. The company has expanded its market reach through strategic collaborations and international sales of domestically developed products.
YTD Price Performance: 0.73%
Average Trading Volume: 189,947
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$780.3M
For an in-depth examination of 2170 stock, go to TipRanks’ Stock Analysis page.